This Undervalued Dividend King Could Have 18% Upside Potential

Barclays' recent upgrade of 3M's stock to Overweight, coupled with a new CEO at the helm and a promising spin-off of its healthcare segment, suggests that this Dividend King may be an undervalued investment with significant upside potential. https://www.nasdaq.com/articles/this-undervalued-dividend-king-could-have-18-upside-potential